Stockreport

Artelo Biosciences stock soars 40% on pre-clinical data for ART27.13 in cancer-related muscle degeneration [Seeking Alpha]

Artelo Biosciences, Inc.  (ARTL) 
US:NASDAQ Investor Relations: artelobio.com/investors
PDF Artelo Biosciences stock soars 40% on pre-clinical data for ART7.13 in cancer-related muscle degenerationApr. 13, 0 8:53 AM ETArtelo Biosciences, Inc. ()By: RavikashSA N [Read more]